The OCEANIC-AF trial has raised concerns about factor XI inhibitors. Should physicians still bet on this class of ...

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...

The Hong Kong company saw a reduction in body weight across both cohorts with no serious adverse events reported.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

A photothermal, nanoparticle-based deep brain stimulation system restored motor skills in mice with Parkinson’s-like disease ...